icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
13 May, 2010 13:04

Veropharm posts FY 2009 net profit of 1.107 billion roubles

Veropharm posts FY 2009 net profit of 1.107 billion roubles

Russian drugmaker, Veropharm, has posted a FY 2009 net income of 1.107 billion rubles under IFRS.

The bottom line was up 20% year on year, with FY EBITDA rising 6% to 1.389 billion roubles, as FY 2009 sales rose 2% 4.395 billion roubles.

The company highlighted the contribution of its 79 million rouble upgrade of its production facilities as well as noting a 3% rise prescription drugs with over the counter drug sales rising from 9% to 12% of the total sales mix over the course of the year. Veropharm also disclosed that its debts, at 981 million roubles, comprised less than 20% of its net assets.